Literature DB >> 21192280

The heat shock paradox and cardiac myocytes: role of heat shock factor.

Samuel Kobba1, Se-Chan Kim, Le Chen, Eunjung Kim, Alice L Tran, Pascal Knuefermann, Anne A Knowlton.   

Abstract

The induction of the heat shock (HS) response is accepted to be a protective response, reducing injury and improving cell survival. However, when inflammation precedes HS, there is an unexpected increase in injury, known as the HS paradox, which is hypothesized to be a mechanism underlying multiorgan dysfunction. We hypothesized that the HS paradox would occur in adult cardiac myocytes and that HS factor (HSF) 1 would contribute to injury. Heat shock at 42°C and TNF (10 ng/mL) were used as the HS and the inflammatory insult, respectively. The combination of TNF followed by HS (TNF/HS) caused the greatest amount of apoptosis in adult rat cardiac myocytes. TNF/HS resulted in an increase in HS protein (HSP) 60, compared with untreated cells, those receiving HS/TNF, or TNF alone. There was no increase in heme oxygenase 1 in any of the groups. Heat shock protein 72 increased in all the groups, with the greatest levels with TNF/HS. Nuclear factor κB activation was greatest with TNF/HS. Pretreatment with a DNA-binding decoy for HSF-1 prevented the increase in HSPs and decreased apoptosis in all groups. However, the increase in iNOS, seen in all treatment groups, was unaffected by the HSF-1-binding decoy. We conclude that the HS paradox occurs in adult cardiac myocytes, that HSP60 is increased as part of the HS paradox, and that HSF-1 activation contributes to injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21192280      PMCID: PMC3435103          DOI: 10.1097/SHK.0b013e3182094a0b

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  35 in total

1.  TNFalpha mediates susceptibility to heat-induced apoptosis by protein phosphatase-mediated inhibition of the HSF1/hsp70 stress response.

Authors:  G Schett; C-W Steiner; Q Xu; J S Smolen; G Steiner
Journal:  Cell Death Differ       Date:  2003-10       Impact factor: 15.828

2.  NFkappaB, heat shock proteins, HSF-1, and inflammation.

Authors:  A A Knowlton
Journal:  Cardiovasc Res       Date:  2005-12-07       Impact factor: 10.787

3.  Influence of sex and age on mods and cytokines after multiple injuries.

Authors:  Michael Frink; Hans-Christoph Pape; Martijn van Griensven; Christian Krettek; Irshad H Chaudry; Frank Hildebrand
Journal:  Shock       Date:  2007-02       Impact factor: 3.454

4.  Activation of HSF and selective increase in heat-shock proteins by acute dexamethasone treatment.

Authors:  L Sun; J Chang; S R Kirchhoff; A A Knowlton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-04       Impact factor: 4.733

5.  Induction of heat shock response leads to apoptosis in endothelial cells previously exposed to endotoxin.

Authors:  T G Buchman; P A Abello; E H Smith; G B Bulkley
Journal:  Am J Physiol       Date:  1993-07

6.  Sequential phosphorylation by mitogen-activated protein kinase and glycogen synthase kinase 3 represses transcriptional activation by heat shock factor-1.

Authors:  B Chu; F Soncin; B D Price; M A Stevenson; S K Calderwood
Journal:  J Biol Chem       Date:  1996-11-29       Impact factor: 5.157

7.  Blocking the endogenous increase in HSP 72 increases susceptibility to hypoxia and reoxygenation in isolated adult feline cardiocytes.

Authors:  M Nakano; D L Mann; A A Knowlton
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

8.  Regulation of heat shock protein 60 and 72 expression in the failing heart.

Authors:  Y Wang; L Chen; N Hagiwara; A A Knowlton
Journal:  J Mol Cell Cardiol       Date:  2009-11-27       Impact factor: 5.000

9.  Estrogen, heat shock proteins, and NFkappaB in human vascular endothelium.

Authors:  Karyn L Hamilton; F N Mbai; S Gupta; A A Knowlton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-07-01       Impact factor: 8.311

10.  Analysis of phosphorylation of human heat shock factor 1 in cells experiencing a stress.

Authors:  Toumy Guettouche; Frank Boellmann; William S Lane; Richard Voellmy
Journal:  BMC Biochem       Date:  2005-03-11       Impact factor: 4.059

View more
  6 in total

1.  Heat shock protein 25-enriched plasma transfusion preconditions the heart against doxorubicin-induced dilated cardiomyopathy in mice.

Authors:  Karthikeyan Krishnamurthy; Ragu Kanagasabai; Lawrence J Druhan; Govindasamy Ilangovan
Journal:  J Pharmacol Exp Ther       Date:  2012-03-21       Impact factor: 4.030

2.  TLR4 mutation and HSP60-induced cell death in adult mouse cardiac myocytes.

Authors:  J P Heiserman; L Chen; B S Kim; S C Kim; A L Tran; N Siebenborn; A A Knowlton
Journal:  Cell Stress Chaperones       Date:  2015-02-27       Impact factor: 3.667

3.  Heat shock factor-1 knockout enhances cholesterol 7α-hydroxylase (CYP7A1) and multidrug transporter (MDR1) gene expressions to attenuate atherosclerosis.

Authors:  Karthikeyan Krishnamurthy; Shannon Glaser; Gianfranco D Alpini; Arturo J Cardounel; Zhenguo Liu; Govindasamy Ilangovan
Journal:  Cardiovasc Res       Date:  2016-04-30       Impact factor: 10.787

4.  Identification of the HSPB4/TLR2/NF-κB axis in macrophage as a therapeutic target for sterile inflammation of the cornea.

Authors:  Joo Youn Oh; Hosoon Choi; Ryang Hwa Lee; Gavin W Roddy; Joni H Ylöstalo; Eric Wawrousek; Darwin J Prockop
Journal:  EMBO Mol Med       Date:  2012-02-22       Impact factor: 12.137

5.  Celastrol inhibits aminoglycoside-induced ototoxicity via heat shock protein 32.

Authors:  S P Francis; I I Kramarenko; C S Brandon; F-S Lee; T G Baker; L L Cunningham
Journal:  Cell Death Dis       Date:  2011-08-25       Impact factor: 8.469

6.  Comparison of the ventricle muscle proteome between patients with rheumatic heart disease and controls with mitral valve prolapse: HSP 60 may be a specific protein in RHD.

Authors:  Dawei Zheng; Limin Xu; Lebo Sun; Qiang Feng; Zishan Wang; Guofeng Shao; Yiming Ni
Journal:  Biomed Res Int       Date:  2014-03-12       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.